一德国生物科技公司称其研发的新冠疫苗有望在今年底接受审核，以进入全球市场

BioNTech是全球共17家研发Covid-19疫苗、并开始进行人体试验的公司之一。BioNTech预计将于7月底开始临床试验的最后阶段，预计试验将在今年年底完成。届时，该公司将申请全球监管机构的批准，以进入市场。

据悉，其他几个进行过疫苗人体试验的公司，包括 Moderna Inc, 与牛津大学合作的AstraZeneca PLC以及强生公司，也将在接下来几个月进入临床试验的最终阶段。

BioNTech, a biotech company, is one of 17 firms world-wide that have started human trials on a vaccine against Covid-19. BioNTech expects to begin the final stage of the testing process at the end of July. The study is expected to be completed by the end of the year, when the company would seek market approval from regulators across the globe.

Other companies already conducting human trials include Moderna Inc., which is also starting its advanced-stage trial this month. In August another vaccine co-developed by the University of Oxford and AstraZeneca PLC will also enter phase 3 trials, followed by a product developed by Johnson & Johnson in September.
  source

指尖新闻：高信噪比，一目了然

新冠疫情追踪